VYTRUS BIOTECH EO -01 (V5P) — Cash Flow Quality Index
VYTRUS BIOTECH EO -01 (V5P) has a Cash Flow Quality Index of 1.35x as of December 2025. Operating cash flow of €3.90 Million exceeds net income of €2.90 Million, indicating high earnings quality where cash backs reported profits. Explore V5P cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
VYTRUS BIOTECH EO -01 Cash Flow Quality Index (2021–2025)
Historical Cash Flow Quality Index for VYTRUS BIOTECH EO -01 across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check V5P total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for VYTRUS BIOTECH EO -01 (2021–2025)
Year-by-year earnings quality comparison for VYTRUS BIOTECH EO -01. For live market cap and the full company financial profile, see V5P market cap overview.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.35x | €3.90 Million | €2.90 Million | ▼ -25.4% |
| 2024 | 1.81x | €1.84 Million | €1.02 Million | ▲ +8.8% |
| 2023 | 1.66x | €904.39K | €544.94K | ▼ -2.1% |
| 2022 | 1.70x | €1.03 Million | €605.26K | ▲ +70.3% |
| 2021 | 1.00x | €447.92K | €450.02K | — |